Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call Transcript

Operator: Good morning, and thank you for standing by. Welcome to the Sangamo Third Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.

Related Keywords

Brisbane ,Queensland ,Australia ,Point Richmond ,California ,United States ,Lisa Rojkjaer ,Nathalie Dubois Stringfellow ,Areena Patel ,Prathyusha Duraibabu ,Kamy Pooler ,Andreas Argyrides ,Greg Davis ,Mark Mcclung ,Jason Fontenot ,Louise Wilkie ,Sandy Macrae ,Head Of Research Amy ,Sangamo Therapeutics Inc ,Pfizer ,Head Of Technology ,Biggest Edtech Companies ,Head Of Research ,Corporate Communications ,Nasdaq ,Sangamo Therapeutics ,Call Transcript November ,Sangamo Third Quarter ,Vice President ,Investor Relations ,Chief Executive Officer ,Chief Operating Officer ,Chief Financial Officer ,Chief Development Officer ,Chief Medical ,Zinc Finger ,Mark Mcclung Executive Vice President ,Senior Vice President ,Chief Scientist Officer ,Genome Engineering ,Blood Brain Barrier Penetrant Capsid ,Research Amy ,Zinc Fingers ,Zinc Finger Cargo ,Blood Brain Barrier ,Blood Brain Barrier Penetrant ,Medtech Companies ,Performing Stocks ,